99m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 1999-2006

  Turhal, Nazim S ^a,c   Dane, Faysal ^a   Dede, Fuat ^a   Gumus, Mahmut ^a   Yumuk, P Fulden ^a   Cakalagaoglu, Fulya ^a   Savci, Dilara ^a   Karaman, Munire ^b   Gulluoglu, Bahadir ^a   Turoglu, H Turgut ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Breast cancer; Mammography; Technetium Tc 99m medronate; VEGF

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; STAINING; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 3242728716     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parkin D-M, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Mettlin C: Global breast cancer mortality statistics. CA Cancer J Clin 49: 138-144, 1999.
3. Greenly R-T, Murray T, Bolden S and Wingo P-A: Cancer statistics. CA Cancer J Clin 50: 7-33, 2000.
4. Donegan W-L: Evalution of a palpable breast masses. N Engl J Med 327: 937-942, 1992.
5. Kopans D-B: The positive predictive value of mammography. AJR 158: 521-526, 1992.
6. Taillefer R: The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 29: 16-40, 1999.
7. American College of Radiology: Breast Imaging Reporting and Data System (BIRADS) ed 2. Reston VA, American College of Radiology, 1995.
8. Scott S and Morrow M: Breast cancer: Making the diagnosis. Surg Clin North Am 79(5): 991-1005, 1999.
9. Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L and Salvatore M: Tc-99m MDP scintimammography to image primary breast cancer. J Nucl Med 36: 718-724, 1995.
10. Piccolo S, Lastoria S, Muto P, Bazzicalupo L, Bartiromo A and Salvatore M: Scintimammograpby with 99mTc-MDP in the detection of primary breast cancer. Quart J Nucl Med 41: 225-230, 1997.
11. Atasever T, Ozdemir A, Turkolmez S, Altinok M and Isik S: Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: Comparison with mammographic probability of malignancy. Anticancer Res 19: 3601-3606, 1999.
12. Waxman A-D, Ramanna L, Memsic L-D, Foster C-E, Silberman A-W, Gleischman S-H, Brenner R-J, Brachman M-B, Kuhar C-J and Yadegar J: Thalium scintigraphy in the evaluation of mass abnormalities of breast. J Nucl Med 34: 18-23, 1993.
13. Worsley D-F and Lentle B-C: Uptake of Tc-99m MDP in primary amyloidosis with a review of mechanism of soft tissue localization of bone seeking radiopharmaceuticals. J Nucl Med 34: 1612-1615, 1993.
14. Schmitt G-H, Holmes R-A, Isitman A-T, Henley G-T and Lewis J-D: A proposed mechanism for Tc-99m labeled polyphosphate and the diphosphonate uptake by human breast tissue. Radiology 12: 733-735, 1974.
15. Burnett K-R, Lyons K-P and Brown W-T: Uptake of osteotropic radionuclides in the breast. Semin Nucl Med 14: 48-49, 1984.
16. Dvorak H-F, Brown L-F, Detmar M and Dvorak A-M: Vascular permeability factor/vascular endothelial growth factor, microvascular permeability and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
17. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes J-C and Abraham J-A: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
18. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
19. Brown L-F, Guidi A-J, Schnitt S-J, Van De Water L, Iruela-Arispe M-L, Yeo T-K, Tognazzi K and Dvorak H-F: Vascular stroma formation in carcinoma in situ, invasive carcinoma and metastatic carcinoma of the breast. Clin Cancer Res 5: 1041-1056, 1999.
20. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer Jpn J Cancer Res 85: 1045-1049, 1994.
21. Sickles EA: Mammographic features of early breast cancer. AJR 143: 461-464, 1984.
22. Mann B-D, Giuliano A-E, Bassett L-W, Barber M-S, Hallauer W and Morton D-L: Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg 118: 23-25, 1983.
23. Liberman L, Abramson A-F, Squires F-B, Glassman J-R, Morris E-A and Dershaw D-D: The Breast Imaging Reporting and Data System: Positive predictive value of mammographic features and final assessment categories. AJR 171: 35-40, 1998.
24. Palmedo H, Biersack H-J, Lastoria S, Maublant J, Prats E, Stegner H-E, Bourgeois P, Hustinx R, Hilson A-J and Bischof-Delaloye A: Scintimammography with Tc-99m methoxyisobutylisonitrile: Results of a prospective European multicentre trial. Eur J Nucl Med 25: 375-385, 1998.
25. Kao C-H, Wang S-J and Liu T-J: The use of Tc-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994.
26. Khalkhali I, Villanueva-Meyer J, Edell S-L, Connoly J-L, Schnitt S-J, Baum J-K, Houlihan M-J, Jenkins R-M and Haber S-B: Diagnostic accuracy of Tc-99m sestamibi breast imaging: multicenter trial results. J Nucl Med 41(12): 1973-1979, 2000.
27. Tiling R, Khalkhali I, Sommer H, Moser R, Meyer G, Willemsen F, Pfluger T, Tatsch K and Hahn K: Role of technetium 99m scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Eur J Nucl Med 24: 1221-1229, 1997.
28. Berg J-R, Kalisher L, Osmond J-D, Pendergrass H-P and Potsaid M-S: Technetium-99m-diphosphonate concentration in primary breast cancer. Radiology 109: 393-394, 1973.
29. Uno K, Uchida Y, Sakata S, Minoshima S, Okada J, Yoshikawa K, Arimizu N, Karikomi M, Kitakata Y and Suzuki Y: Visualisation of female breast in bone scintigraphy. Kaku Igaku 29: 1201-1205, 1992.
30. Datz FL: Gamuts in Nuclear Medicine, 3rd ed. St. Louis, Mosby, 175-176, 1977.
31. Dimonte M, Leo G, Marsigliante S and Manca C: The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters (abstr). Radiol Med 98(5): 352-355, 1999.
32. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
33. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis Nat Med 6: 389-395, 2000.
34. Folkman J: Angiogenesis. In: Braunwald E, Fauci A-S, Kasper D-L, Hauser S-L, Longo D-L, Jameson J-L (eds). Harrison's Textbook of Internal Medicine, 15th Edition, McGraw-Hill. 517-530, 2001.
35. Horak E-R, Leek R, Klenk N, LeJune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris A-L: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
36. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E-N, Moore D-H, Meli S and Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
37. Gasparini G: Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 37: 97-114, 2001.
38. Collingridge D-R, Carroll V-A, Glaser M, Aboagye E-O, Osman S, Hutchinson O-C, Barthel H, Luthra S-K, Brady F, Bicknell R, Price P and Harris A-L: The development of ((124)I) iodinated-VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res 62: 5912-5919, 2002.
39. Kim S-W, Park S-S, Ahn S-J, Chung K-W, Moon W-K, Im J-G, Yeo J-S, Chung J-K and Noh D-Y: Identification of angiogenesis in primary breast carcinoma according to image analysis. Breast Cancer Res Treat 74 (2): 121-129, 2002.